Market Position CuraScript, as part of the Express Scripts ecosystem, operates within the competitive specialty pharmacy sector with a notable revenue range of 250 to 500 million dollars, indicating a solid market presence that potential clients and partners may find attractive.
Strategic Focus The company's focus on specialty pharmacy and pharmaceutical manufacturing presents opportunities to collaborate on complex medication management and high-value treatment plans for healthcare providers and insurers.
Growth Potential With an employee base of up to 500, CuraScript appears poised for growth or strategic expansion, making it an ideal partner for scalable solutions in pharmacy logistics, technology, or healthcare services.
Technology Leverage Given the absence of explicit technology details, there is potential to introduce innovative pharmacy management systems or digital health tools to enhance efficiency and patient engagement.
Industry Trends The company's position within an evolving pharmacy landscape driven by pharma innovation and personalized medicine opportunities highlights avenues for tailored product offerings and collaborative ventures focusing on emerging therapies.
| CuraScript, Inc. An Express Scripts Co. Email Formats | Percentage |
| First.Last@curascript.com | 85% |
| FLast@curascript.com | 13% |
| Last.First@curascript.com | 1% |
| LastF@curascript.com | 1% |
Pharmaceutical ManufacturingUnited States201-500 Employees
The specialty pharmacy business of CuraScript, Inc., an Express Scripts company, is now owned and operated by Accredo Health Group, Inc., an Express Scripts company. To see what's new, visit the Accredo LinkedIn page or accredo.com.
Company Overview
Funding & FinancialsCuraScript, Inc. An Express Scripts Co.'s revenue is estimated to be in the range of $250M$500M
Funding & FinancialsCuraScript, Inc. An Express Scripts Co.'s revenue is estimated to be in the range of $250M$500M
1-888-653-2347 
support@leadiq.com